Open
Do antihypertensives improve all-cause mortality more than other treatments?
Not modeled yetTrial evidence exists, but no mechanistic model yetWithout a model there is no decisive experiment to propose. Help build it. →
Where the evidence stands
No claim has formed for this comparison yet. The trials below are registered, but none decides it.
Already under way
No registered trial that could settle this is recruiting or active.
The evidence so far
- Registered trials
- 25
- With posted results
- 2
- Published papers
- 4
Papers
- Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy.Meta-analysis / systematic review · 2016
- Determining optimal strategies for primary prevention of cardiovascular disease: a synopsis of an evidence synthesis study.Meta-analysis / systematic review · 2025
- Impact of statin therapy on clinical outcomes in chronic heart failure patients according to beta-blocker use: results of CIBIS II.Trial report · 2007
- The importance of proteinuria and prior cardiovascular disease in all major clinical outcomes of atherosclerotic renovascular disease - a single-center observational study.Observational study · 2016
Trials
- Study of Curative Effect Evaluation of DanLou Tablet on Coronary Artery Disease Not Amenable to Revascularization on the Basis of Western Medicine TherapyNCT03072082
- Study of Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization on the Basis of Western Medicine TherapyNCT03072121
- Evaluation of a POlypill and Colchicine for Risk Reduction in Patients With Established Atherosclerotic Cardiovascular Disease: The EPOCA Randomized Clinical TrialNCT06930885
- Heart Outcomes Prevention Evaluation-3NCT00468923
- Impact of Finerenone in Combination With Sodium Glucose Cotransporter-2 Inhibitor in Patients With Heart FailureNCT07351864
- Carotid Endarterectomy Versus Optimal Medical Treatment of Asymptomatic High Grade Carotid Artery StenosisNCT00805311
- Prevention of Renal and Vascular Endstage Disease Intervention TrialNCT03073018
- Effect of Pioglitazone on Insulin Resistance, Progression of Atherosclerosis and Clinical Course of Coronary Heart DiseaseNCT03011775 · 1 posted result